Portal vein thrombosis and liver transplantation: Implications for waiting list period, surgical approach, early and late follow-up

Transplantation Reviews

Volumn 28, Issue 2, 2014, Pages 92-101

  Ponziani, Francesca Romana ^a   Zocco, Maria Assunta ^a   Senzolo, Marco ^b   Pompili, Maurizio ^a   Gasbarrini, Antonio ^a   Avolio, Alfonso Wolfango ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; AUTOIMMUNE HEPATITIS; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; EVIDENCE BASED PRACTICE; FOLLOW UP; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORTALITY; OPERATION DURATION; PORTAL VEIN THROMBOSIS; POST TREATMENT SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE THROMBOSIS; PROGNOSIS; RECURRENT DISEASE; REOPERATION; REVIEW; SYSTEMATIC REVIEW; THROMBOSIS PREVENTION; TREATMENT OUTCOME; COMORBIDITY; FEMALE; GRAFT REJECTION; HOSPITAL ADMISSION; MALE; PATHOPHYSIOLOGY; PATIENT SELECTION; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SURVIVAL; TIME; VENOUS THROMBOSIS;

COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PATIENT SELECTION; PORTAL VEIN; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOSIS; WAITING LISTS;

EID: 84897086885     PISSN: 0955470X     EISSN: 15579816     Source Type: Journal    
DOI: 10.1016/j.trre.2014.01.003     Document Type: Review

References (112)

1. Lendoire J., Raffin G., Cejas N., et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford) 2007, 9:352-356.
2. Ramos A.P., Reigada C.P., Ataide E.C., Almeida J.R., Cardoso A.R., Caruy C.A., et al. Portal vein thrombosis and liver transplantation: long term. Transplant Proc 2010, 42:498-501.
3. Ponziani F.R., Zocco M.A., Campanale C., et al. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol 2010, 16:143-155. [Review].
4. Amitrano L., Guardascione M.A., Brancaccio V., et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004, 40:736-741.
5. Wang J.T., Zhao H.Y., Liu Y.L. Portal vein thrombosis. Hepatobiliary Pancreat Dis Int 2005, 4:515-518. [Review].
6. Stieber A.C., Zetti G., Todo S., et al. The spectrum of portal vein thrombosis in liver transplantation. Ann Surg 1991, 213:199-206.
7. Shaked A., Busuttil R.W. Liver transplantation in patients with portal vein thrombosis and central portacaval shunts. Ann Surg 1991, 214:696-702. [Research Support, Non-U.S. Gov't].
8. Langnas A.N., Marujo W.C., Stratta R.J., et al. A selective approach to preexisting portal vein thrombosis in patients undergoing liver transplantation. Am J Surg 1992, 163:132-136.
9. Cherqui D., Duvoux C., Rahmouni A., et al. Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: problems in diagnosis and management. World J Surg 1993, 17:669-674.
10. Moreno Gonzalez E., Garcia Garcia I., Gomez Sanz R., Gonzalez-Pinto I., Loinaz Segurola C., Jimenez Romero C. Liver transplantation in patients with thrombosis of the portal, splenic or superior mesenteric vein. Br J Surg 1993, 80:81-85.
11. Seu P., Shackleton C.R., Shaked A., et al. Improved results of liver transplantation in patients with portal vein thrombosis. Arch Surg 1996, 131:840-844. [discussion 4-5].
12. Gayowski T.J., Marino I.R., Doyle H.R., et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996, 60:333-338.
13. Lerut J.P., Mazza D., van Leeuw V., et al. Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients. Transpl Int 1997, 10:125-132.
14. Figueras J., Torras J., Rafecas A., et al. Extra-anatomic venous graft for portal vein thrombosis in liver transplantation. Transpl Int 1997, 10:407-408. [Comment Letter].
15. Yerdel M.A., Gunson B., Mirza D., et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000, 69:1873-1881. [Research Support, Non-U.S. Gov't].
16. Manzanet G., Sanjuan F., Orbis P., et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 2001, 7:125-131.
17. Molmenti E.P., Roodhouse T.W., Molmenti H., et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002, 235:292-296.
18. Dumortier J., Czyglik O., Poncet G., et al. Eversion thrombectomy for portal vein thrombosis during liver transplantation. Am J Transplant 2002, 2:934-938. [Comparative Study].
19. Gimeno F.A., Calvo J., Loinaz C., et al. Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc 2005, 37:3899-3903. [Comparative Study].
20. Francoz C., Belghiti J., Vilgrain V., et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005, 54:691-697. [Evaluation Studies].
21. Llado L., Fabregat J., Castellote J., et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant 2007, 21:716-721. [Comparative Study].
22. Arcadipane A., Nadalin S., Gruttadauria S., et al. The recipient with portal thrombosis and/or previous surgery. Transplant Proc 2008, 40:1183-1186.
23. Cho J.Y., Suh K.S., Shin W.Y., Lee H.W., Yi N.J., Lee K.U. Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation. World J Surg 2008, 32:1731-1737.
24. Tao Y.F., Teng F., Wang Z.X., et al. Liver transplant recipients with portal vein thrombosis: a single center retrospective study. Hepatobiliary Pancreat Dis Int 2009, 8:34-39.
25. Pan C., Shi Y., Zhang J.J., et al. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China. Transplant Proc 2009, 41:3761-3765.
26. Doenecke A., Tsui T.Y., Zuelke C., et al. Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clinical Transplant 2010, 24:48-55.
27. Englesbe M.J., Kubus J., Muhammad W., et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010, 16:83-90. [Research Support, Non-U.S. Gov't].
28. Suarez Artacho G., Barrera Pulido L., Alamo Martinez J.M., et al. Outcomes of liver transplantation in candidates with portal vein thrombosis. Transplant Proc 2010, 42:3156-3158.
29. Ravaioli M., Zanello M., Grazi G.L., et al. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg 2011, 253:378-384.
30. Bertelli R., Nardo B., Montalti R., Beltempo P., Puviani L., Cavallari A. Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center. Transplant Proc 2005, 37:1119-1121.
31. Davidson B.R., Gibson M., Dick R., Burroughs A., Rolles K. Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation 1994, 57:1174-1177.
32. Duffy J.P., Hong J.C., Farmer D.G., et al. Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients. J Am Coll Surg 2009, 208:896-903. [[Research Support, Non-U.S. Gov't]; discussion -5].
33. Egawa H., Tanaka K., Kasahara M., et al. Single center experience of 39 patients with preoperative portal vein thrombosis among 404 adult living donor liver transplantations. Liver Transpl 2006, 12:1512-1518. [Comparative Study].
34. Karatzas T., Lykaki-Karatzas E., Demirbas A., et al. Management of portal vein thrombosis in liver transplantation. Transplant Proc 1997, 29:2866-2867. [Comparative Study].
35. Orlando G., De Luca L., Toti L., et al. Liver transplantation in the presence of portal vein thrombosis: report from a single center. Transplant Proc 2004, 36:199-202.
36. Robles R., Fernandez J.A., Hernandez Q., et al. Eversion thromboendovenectomy in organized portal vein thrombosis during liver transplantation. Clin Transplant 2004, 18:79-84.
37. Sharma R., Kashyap R., Jain A., et al. Surgical complications following liver transplantation in patients with portal vein thrombosis-a single-center perspective. J Gastrointest Surg 2010, 14:520-527. [Comparative Study].
38. Shi Z., Yan L., Zhao J., et al. Prevention and treatment of rethrombosis after liver transplantation with an implantable pump of the portal vein. Liver Transpl 2010, 16:324-331.
39. Nikitin D., Jennings L.W., Khan T., et al. Twenty years' follow-up of portal vein conduits in liver transplantation. Liver Transpl 2009, 15:400-406. [Case Reports].
40. Wu G., Liu Y.F., Liu S.R., Zhang J.L., Chen X.C., Cheng D.H. Liver transplantation in end-stage liver disease with portal vein thrombosis 2009, 47:590-593.
41. Gao P.J., Zhu J.Y., Li G.M., Leng X.S. Liver transplantation for the patients with end stage liver disease and portal vein thrombosis 2009, 41:558-560.
42. Wu T.H., Lin Y.S., Lee C.F., et al. Clinical analysis and strategy for liver transplantation in patients with pre-existing portal vein thrombosis. Chang Gung Med J 2011, 34:426-434.
43. Zocco M.A., Di Stasio E., De Cristofaro R., et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009, 51:682-689. [Research Support, Non-U.S. Gov't].
44. Nonami T., Yokoyama I., Iwatsuki S., Starzl T.E. The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992, 16:1195-1198. [Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.].
45. Piscaglia F., Gianstefani A., Ravaioli M., et al. Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. Liver Int 2010, 16:658-667. [Clinical Trial].
46. Oxford Centre for Evidence-based Medicine Levels of Evidence [Accessed on July 2012]; Available from:. http://www.cebm.net.
47. Englesbe M.J., Schaubel D.E., Cai S., Guidinger M.K., Merion R.M. Portal vein thrombosis and liver transplant survival benefit. Liver Int 2010, 16:999-1005. [Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S.].
48. Shaw B.W., Iwatsuki S., Bron K., Starzl T.E. Portal vein grafts in hepatic transplantation. Surg Gynecol Obstet 1985, 161:66-68.
49. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96.
50. Weismuller T.J., Fikatas P., Schmidt J., et al. Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany-limitations of the 'sickest first'-concept. Transpl Int 2011, 24:91-99. [Multicenter StudyResearch Support, Non-U.S. Gov't].
51. Dutkowski P., Schlegel A., Slankamenac K., et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg 2012, 256:861-868. [[Research Support, Non-U.S. Gov't]; discussion 8-9].
52. Tzakis A., Todo S., Stieber A., Starzl T.E. Venous jump grafts for liver transplantation in patients with portal vein thrombosis. Transplantation 1989, 48:530-531.
53. Paskonis M., Jurgaitis J., Mehrabi A., et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis-current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transplant 2006, 20:551-562. [Case Reports Review].
54. Jamieson N.V. Changing perspectives in portal vein thrombosis and liver transplantation. Transplantation 2000, 69:1772-1774. [Comment].
55. Tzakis A.G., Kirkegaard P., Pinna A.D., et al. Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation 1998, 65:619-624.
56. Cavallari A., Vivarelli M., Bellusci R., Jovine E., Mazziotti A., Rossi C. Treatment of vascular complications following liver transplantation: multidisciplinary approach. Hepatogastroenterology 2001, 48:179-183.
57. Azoulay D., Hargreaves G.M., Castaing D., Bismuth H. Caval inflow to the graft: a successful way to overcome diffuse portal system thrombosis in liver transplantation. J Am Coll Surg 2000, 190:493-496. [Case Reports].
58. Bhangui P., Lim C., Salloum C., et al. Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience. Ann Surg 2011, 254:1008-1016. [Comparative Study].
59. Williams J.W., Britt L.G., Peters T.G., Vera S.R., Haggitt R.C. Portal vein obstruction in patients requiring hepatic resection or transplantation. Am Surg 1984, 50:465-468. [Case Reports].
60. Czerniak A., Badger I., Sherlock D., Buckels J. Orthotopic liver transplantation in a patient with thrombosis of the hepatic portal and superior mesenteric veins. Transplantation 1990, 50:334-336. [Case Reports].
61. Hiatt J.R., Quinones-Baldrich W.J., Ramming K.P., Lois J.F., Busuttil R.W. Bile duct varices. An alternative to portoportal anastomosis in liver transplantation. Transplantation 1986, 42:85. [Case Reports].
62. Santoni P., Johanet H., Pras-Jude N., Houssin D., Chapuis Y. Orthotopic liver transplantation in patients with complete obliteration of the portal vein. Transplant Proc 1990, 22:1569-1570. [Case Reports].
63. Rudroff C., Scheele J. The middle colic vein: an alternative source of portal inflow in orthotopic liver transplantation complicated by portal vein thrombosis. Clinical Transplant 1998, 12:538-542. [Case Reports].
64. Castaldo P., Langnas A.N., Stratta R.J., Lieberman R.P., Wood R.P., Shaw B.W. Successful liver transplantation in a patient with a thrombosed portomesenteric system after multiple failed shunts. Am J Gastroenterol 1991, 86:506-508. [Case Reports].
65. Maluf D., Shim I., Posner M., Cotterell A.H., Fisher R.A. Salvage procedure for unexpected portal vein thrombosis in living donor liver transplantation. Transplant Proc 2006, 38:1422-1424. [Case Reports].
66. Kirsch J.P., Howard T.K., Klintmalm G.B., Husberg B.S., Goldstein R.M. Problematic vascular reconstruction in liver transplantation. Part II. Portovenous conduits. Surgery 1990, 107:544-548.
67. Azoulay D., Adam R., Castaing D., et al. Liver transplantation with cavoportal or renoportal anastomosis: a solution in cases of diffuse portal thrombosis. Gastroenterol Clin Biol 2002, 26:325-330. [Clinical Trial].
68. Monbaliu D., Pirenne J., Talbot D. Liver transplantation using donation after cardiac death donors. J Hepatol 2012, 56:474-485. [Research Support, Non-U.S. Gov't Review].
69. Lai J.C., Feng S., Roberts J.P. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology 2012, 143:1261-1265. [Research Support, N.I.H., Extramural].
70. Avolio A.W., Cillo U., Salizzoni M., et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant 2011, 11:2724-2736. [Research Support, Non-U.S. Gov't].
71. Avolio A.W., Siciliano M., Barbarino R., et al. Donor risk index and organ patient index as predictors of graft survival after liver transplantation. Transplant Proc 2008, 40:1899-1902.
72. Frongillo F., Avolio A.W., Nure E., et al. Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival. Transplant Proc 2009, 41:1268-1272.
73. Avolio A.W., Burra P. Can we match donors and recipients in a cost-effective way?. Transpl Int 2013, 26(11):1061-1062.
74. Selvaggi G., Weppler D., Nishida S., et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant 2007, 7:454-460. [Evaluation Studies].
75. Primignani M. Portal vein thrombosis, revisited. Dig Liver Dis 2010, 42:163-170. [Review].
76. Llop E., de Juan C., Seijo S., et al. Portal cholangiopathy: radiological classification and natural history. Gut 2011, 60:853-860. [Research Support, Non-U.S. Gov't].
77. Merion R.M., Schaubel D.E., Dykstra D.M., Freeman R.B., Port F.K., Wolfe R.A. The survival benefit of liver transplantation. Am J Transplant 2005, 5:307-313. [Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.].
78. Avolio A.W., Siciliano M., Barone M., et al. Model for End-stage Liver Disease Stratification of Survival Benefit in a 5-Year Evaluation of an Italian Liver Transplant Program. Transplant Proc 2012, 44(7):1851-1856.
79. Vibert E., Azoulay D., Castaing D., Bismuth H. Portal cavenorma: diagnosis, aetiologies and consequences. Ann Chir 2002, 127:745-750. [Review].
80. Condat B., Vilgrain V., Asselah T., et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 2003, 37:1302-1308.
81. Avolio A.W., Agnes S., Cillo U., et al. http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation. Transpl Int 2012, 25:294-301. [Evaluation Studies Research Support, Non-U.S. Gov't].
82. Avolio A.W., Halldorson J.B., Burra P., Dutkowski P., Agnes S., Clavien P.A. Balancing Utility and Need by Means of Donor-to-Recipient Matching: A Challenging Problem. Am J Transplant 2013, 13:522-523. [Letter].
83. DeLeve L.D., Valla D.C., Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009, 49:1729-1764. [Practice Guideline].
84. Amitrano L., Guardascione M.A., Brancaccio V., Iannaccone L., Ames P.R., Balzano A. Portal and mesenteric venous thrombosis in cirrhotic patients. Gastroenterology 2002, 123:1409-1410. [Case Reports Letter].
85. Guglielmelli P., Barosi G., Specchia G., et al. Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele. Blood 2009, 114:1477-1483.
86. Garcia-Fuster M.J., Abdilla N., Fabia M.J., Fernandez C., Oliver V., Forner M.J. Venous thromboembolism and liver cirrhosis. Rev Esp Enferm Dig 2008, 100:259-262.
87. Senzolo M., Ferronato C., Burra P., Sartori M.T. Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered. Intern Emerg Med 2009, 4:161-162. [[Comment Letter]. author reply 3-4].
88. Villa E., Camma C., Marietta M., et al. Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients with Advanced Cirrhosis. Gastroenterology 2012, 143(5):1253-1260.
89. Romero-Gomez M., Gutierrez-Tous R., Delgado-Mije D. Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology 2002, 122:2095. [Comment Letter].
90. Amitrano L., Guardascione M.A., Menchise A., et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010, 44:448-451.
91. Condat B., Pessione F., Hillaire S., et al. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology 2001, 120:490-497.
92. Chawla Y., Duseja A., Dhiman R.K. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther 2009, 30:881-894. [Review].
93. Belli L., Romani F., Sansalone C.V., Aseni P., Rondinara G. Portal thrombosis in cirrhotics. A retrospective analysis. Ann Surg 1986, 203:286-291. [Comparative Study].
94. Deitcher S.R. Interpretation of the international normalised ratio in patients with liver disease. Lancet 2002, 359:47-48. [Letter].
95. Baril N., Wren S., Radin R., Ralls P., Stain S. The role of anticoagulation in pylephlebitis. Am J Surg 1996, 172:449-452. [[Clinical Trial]; discussion 52-3].
96. Bauer J., Johnson S., Durham J., et al. The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis. Liver Transpl 2006, 12:1544-1551. [Comparative Study].
97. Amitrano L., Guardascione M.A. Management of portal vein thrombosis in cirrhotic patients. Med J Hematol Infect Dis 2009, 1:e2009014. 10.4084/MJHID.2009.014.
98. Perarnau J.M., Baju A., D'Alteroche L., Viguier J., Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol 2010, 22:1093-1098.
99. Senzolo M., Tibbals J., Cholongitas E., Triantos C.K., Burroughs A.K., Patch D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation. Aliment Pharmacol Ther 15 2006, 23:767-775. [Evaluation Studies].
100. Han G., Qi X., Guo W., Niu J., Bai M., Fan D. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis in cirrhosis. Gut 2012, 61:326-327. [Comment Letter].
101. Luca A., Miraglia R., Caruso S., et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut 2011, 60:846-852. [Evaluation Studies].
102. Mancuso A., Watkinson A., Tibballs J., Patch D., Burroughs A.K. Budd-Chiari syndrome with portal, splenic, and superior mesenteric vein thrombosis treated with TIPS: who dares wins. Gut 2003, 52:438. [Case Reports].
103. Han G., Qi X., He C., et al. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis. J Hepatol 2011, 54:78-88.
104. Ganger D.R., Klapman J.B., McDonald V., et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 1999, 94:603-608.
105. Liatsos C., Vlachogiannakos J., Patch D., et al. Successful recanalization of portal vein thrombosis before liver transplantation using transjugular intrahepatic portosystemic shunt. Liver Transpl 2001, 7:453-460. [Case Reports].
106. Francoz C., Valla D., Durand F. Portal vein thrombosis, cirrhosis, and liver transplantation. J Hepatol 2012, 57:203-212.
107. Novi M., Lauritano E.C., Piscaglia A.C., et al. Portal vein tumor thrombosis revascularization during sorafenib treatment for hepatocellular carcinoma. Am J Gastroenterol 2009, 104:1852-1854. [Case Reports Letter].
108. Kanazawa H., Sakamoto S., Fukuda A., et al. Portal vein reconstruction in pediatric living donor liver transplantation for patients younger than 1 year with biliary atresia. J Pediatr Surg 2012, 47:523-527. [Comparative Study Evaluation Studies].
109. Busuttil R.W., Seu P., Millis J.M., et al. Liver transplantation in children. Ann Surg 1991, 213:48-57. [Research Support, Non-U.S. Gov't].
110. McLin V.A., Rimensberger P., Belli D.C., Wildhaber B.E. Anticoagulation following pediatric liver transplantation reduces early thrombotic events. Pediatr Transplant 2011, 15:117-118. [Comment Letter].
111. Ooi C.Y., Brandao L.R., Zolpys L., et al. Thrombotic events after pediatric liver transplantation. Pediatr Transplant 2010, 14:476-482.
112. Woo D.H., Laberge J.M., Gordon R.L., Wilson M.W., Kerlan R.K. Management of portal venous complications after liver transplantation. Tech Vasc Interv Radiol 2007, 10:233-239.